Genetic alterations in head and neck squamous cell carcinomas

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Head and neck cancers are characterized by genetic alterations, including oncogene activation and tumor suppressor gene inactivation.
• Key genes involved are MYC, ERBB-2, EGFR, CyclinD1, p16, and TP53.
• Loss of heterozygosity suggests involvement of unidentified tumor suppressor genes.

Purpose of the Study:

• To review the genetic alterations in head and neck cancer.
• To highlight the role of oncogenes and tumor suppressor genes.
• To emphasize the need for further research into genetic alterations for diagnostic and prognostic markers.

Main Methods:

• Review of genetic alterations in head and neck cancer.
• Analysis of oncogene and tumor suppressor gene mutations, amplifications, and epigenetic modifications.
• Examination of loss of heterozygosity patterns.

Main Results:

• Genetic alterations include oncogene amplification/overexpression (MYC, ERBB-2, EGFR, CyclinD1) and tumor suppressor gene inactivation (p16, TP53) via mutations, deletions, or hypermethylation.
• Frequent loss of heterozygosity indicates potential roles for other tumor suppressor genes.
• The precise sequence and significance of these alterations in head and neck squamous cell carcinoma (HNSCC) development remain unclear.

Conclusions:

• Genetic alterations are central to head and neck cancer development.
• Further understanding of molecular basis is crucial for identifying novel diagnostic, prognostic, and therapeutic markers.
• Research is needed to define the temporal sequence and clinical significance of genetic alterations in HNSCC.